ProMIS Neurosciences Inc.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PMN and other ETFs, options, and stocks.About PMN
ProMIS Neurosciences, Inc. engages in the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases. It focuses on the progression of Alzheimer's disease, amyotrophic lateral sclerosis, and Parkinson's disease.
CEONeil K. Warma
CEONeil K. Warma
Employees7
Employees7
HeadquartersToronto, Ontario
HeadquartersToronto, Ontario
Founded2004
Founded2004
Employees7
Employees7
PMN Key Statistics
Market cap18.26M
Market cap18.26M
Price-Earnings ratio-0.45
Price-Earnings ratio-0.45
Dividend yield—
Dividend yield—
Average volume22.55K
Average volume22.55K
High today$8.53
High today$8.53
Low today$8.27
Low today$8.27
Open price$8.53
Open price$8.53
Volume12.89K
Volume12.89K
52 Week high$39.75
52 Week high$39.75
52 Week low$6.27
52 Week low$6.27
Stock Snapshot
With a market cap of 18.26M, ProMIS Neurosciences Inc.(PMN) trades at $8.49. The stock has a price-to-earnings ratio of -0.45.
During the trading session on 2026-01-09, ProMIS Neurosciences Inc.(PMN) shares reached a daily high of $8.53 and a low of $8.27. At a current price of $8.49, the stock is +2.7% higher than the low and still -0.4% under the high.
Trading activity shows a volume of 12.89K, compared to an average daily volume of 22.55K.
The stock's 52-week range extends from a low of $6.27 to a high of $39.75.
The stock's 52-week range extends from a low of $6.27 to a high of $39.75.
People also own
Based on the portfolios of people who own PMN. This list is generated using Robinhood data, and it’s not a recommendation.